Venous access port assembly with X-ray discernable indicia

Information

  • Patent Grant
  • 8021324
  • Patent Number
    8,021,324
  • Date Filed
    Thursday, July 17, 2008
    16 years ago
  • Date Issued
    Tuesday, September 20, 2011
    13 years ago
Abstract
A venous access port assembly (10) having a housing base (28) with a discharge port (16), a septum (14) and a cap (48), with an interior reservoir (22). The housing base (28) is provided with X-ray discernable indicia (100,200) to identify an attribute of the assembly (10) after its implantation and clearly appear on an X-ray of the patient in a manner informing the radiologist or technologist and the medical practitioner of that particular attribute. Such indicia can be depicted as cutouts (102) through a disc of radiopaque material (100) where the cutouts are in the form of alphabetical letters such as “CT”, or can be a set (200) of discrete elements (202) of radiopaque material, that are affixed along the bottom surface of the housing base or embedded within the thickness of the bottom housing wall.
Description
FIELD OF THE INVENTION

This relates to the field of medical devices and more particularly to venous access ports for the infusion of fluids into the patient and/or withdrawal of fluids from the patient.


BACKGROUND OF THE INVENTION

Venous access ports for the infusion and/or withdrawal of fluids from a patient are well-known, secured to the proximal end of an implanted catheter. These ports are typically used for drug infusion or for withdrawal of small amounts of blood, where large flows of fluid are not required. The ports are assemblies of a needle-impenetrable housing with a discharge port in fluid communication with the catheter and the reservoir within the port housing, and provide a subcutaneous self-sealing septum that defines an access site for multiple needle sticks through the covering skin tissue of the patient, through the septum and into the reservoir, without the need to continuously search for new access sites. Examples of such ports are disclosed, for example, in U.S. Pat. Nos. 4,704,103; 4,762,517; 4,778,452; 5,185,003; 5,213,574 and 5,637,102.


It is desired to provide a venous access port assembly that provides for a radiologist, radiology technologist, nurse and ultimately a medical practitioner to be able to discern an important property of the port assembly after the port assembly has been implanted into a patient.


BRIEF SUMMARY OF THE INVENTION

The present invention is related to a venous access port having a housing and a septum, providing an interior reservoir and a passageway extending from the reservoir through a stem of a discharge port to establish fluid communication with a proximal end of a catheter lumen to which the port assembly is secured prior to placement of the assembly into a patient. The port may optionally have more than one reservoir and associated septum. The invention is the incorporation of X-ray discernable indicia onto a venous access port that is discernible under X-ray examination to provide information concerning the nature or key attribute of the venous access port, so that the practitioner, subsequent to the date of implantation thereof, can determine that nature or key attribute under X-ray examination. One such key attribute in particular would be for example that the venous access port is rated to be used for power injection such as of contrast fluid, wherein for example the letters “CT” (for “computed tomography”, or “contrast enhanced computed tomography”) would be provided that are of radiopaque material, or are cutouts through radiopaque material. The attribute in this example is the property of the port's being adapted to withstand high pressures that are used for injection of contrast fluid into a patient, and the letters “CT” would be understood in medical practice to indicate that the port is suitable for the high pressure injection of contrast fluid.


In one embodiment, a disc of radiopaque material includes cutouts therethrough of letters “CT” (although other indicia may be utilized) through the body of the disc. In another embodiment, discrete letters “CT” (although other indicia may be utilized) are provided of radiopaque material. With either embodiment, the disc or letters may be insert molded within the housing base bottom wall, or they may be affixed to the bottom surface of the housing base, preferably within complementary recesses thereinto, in such a manner that the letters “CT” are readable from above the port assembly in an X-ray.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate the presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain the features of the invention. In the drawings:



FIGS. 1 and 2 are an isometric view and a plan view of the venous access port of the present invention;



FIGS. 3 and 4 are cross-section views of the port of FIGS. 1 and 2 taken along lines 3-3 and lines 4-4 of FIG. 1, respectively;



FIG. 5 is an isometric view of the needle-impenetrable housing base of the venous access port of FIG. 1;



FIGS. 6 and 7 are transverse cross-sectional and longitudinal cross-sectional views of the housing base of FIG. 5;



FIG. 8 is an isometric view of a first embodiment of X-ray discernable indicia, being a disc of radiopaque material having letters cut out thereof;



FIGS. 9 to 11 are bottom, cross-sectional and top views of the port assembly of FIGS. 1 to 7 having the disc of FIG. 8 affixed to the housing base of FIGS. 6 and 7 and within a shallow recess into its bottom surface, with silicone covering molded thereover, and the indicia being shown in dashed lines in FIGS. 9 and 11;



FIG. 12 is a cross-sectional view of an alternate embodiment of housing base having the disc of FIG. 8 insert molded embedded within the bottom wall of the base;



FIG. 13 is an isometric view of a second embodiment of radiopaque indicia, comprising a set of discrete letters of radiopaque material;



FIGS. 14 and 15 are a bottom view and a cross-sectional view of a port assembly of FIGS. 1 to 7 having the discrete letters of FIG. 13 insert molded into the bottom wall of the housing base, with FIG. 15 taken along lines 15-15 of FIG. 13; and



FIGS. 16 to 18 are a bottom view, cross-sectional view and an isometric bottom view of a port assembly of FIGS. 1 to 7 having the discrete letters of FIG. 13 affixed to the bottom surface of the housing base, shown within respective recesses thereinto, with a silicone covering molded thereover, with FIG. 17 taken along lines 17-17 of FIG. 16.





DETAILED DESCRIPTION OF THE INVENTION

Certain terminology is used herein for convenience only and is not to be taken as a limitation on the present invention. The terms “distal” and “proximal” refer, respectively, to directions closer to and away from the insertion tip of a catheter in an implantable catheter assembly. The terminology includes the words specifically mentioned, derivatives thereof and words of similar import. The embodiments illustrated below are not intended to be exhaustive or to limit the invention to the precise form disclosed. These embodiments are chosen and described to best explain the principle of the invention and its application and practical use and to enable others skilled in the art to best utilize the invention.


Venous access port assembly 10 of FIGS. 1 to 4 includes a housing 12 and a septum 14, with a discharge port 16 extending from a distal end 18 of the port assembly 10 to be attached securely and sealingly to the proximal end of a catheter (not shown). A passageway 20 extends from the interior reservoir 22 to the distal tip opening 24 of discharge port 16. A recess 26 is seen to be provided along both sides of discharge port 16, facilitating insertion of the discharge port 16 into the catheter lumen and providing a clearance for a locking sleeve or clamp (not shown) utilized to compress the catheter lumen wall against the exterior surface of the discharge port 16 for assured sealed connection of the catheter with the port assembly 10.


With reference now to FIGS. 3 to 7, the interior of the port assembly 10 is shown to provide an interior reservoir 22. Housing 12 is shown to include a housing base 28 of needle-impenetrable material that includes a well 30 having a bottom floor 32 and side walls 34 that define the interior reservoir 22 beneath septum 14. Bottom floor 32 may be convex or elevated (not shown) toward the center of the reservoir, if desired. Housing base 28 includes a base flange 36 extending radially outwardly from the bottom of well 30, and base flange 36 includes openings 38,40 that serve to enable suturing to the patient upon placement of the venous access port and the attached catheter into the patient.


As shown in FIGS. 3 and 4, a skirt 42 is overmolded about housing base 28 and may be of silicone elastomer. It is seen that skirt 42 encapsulates the outer surfaces of the bottom wall 44 and the bottom portion of the side walls 46 of housing base 28, and is shown to fill in the suture holes 38,40; but since the material is silicone elastomer, suturing is possible since the suturing needle can easily be inserted through the material of skirt 42 and through the suture holes, and thereafter the filled openings provide minimal opportunity for ingrowth of patient tissue into the openings.


Also seen in FIGS. 1 to 4 is cap 48, which secures to housing base 28 to in turn secure septum 14 in position in the port assembly 10. Preferably, skirt 42 is insert molded onto base flange 36 of housing base 28 before cap 48 is secured to the upper portion of housing base 28 to secure the septum in position. It is seen in FIGS. 4 and 7 that discharge port 16 is integral with housing base 28 as is preferable. Discharge port 16 is shown to have a pair of annular ridges 50 that facilitate with the mechanical connection of the catheter proximal end with the port assembly 10. Housing base 28 includes a septum seat 52 extending into the top of well 30, into which a flange of the septum will be seated, preferably under radially inward compression. Housing base 28 has a bottom outer surface 54.



FIG. 8 shows a first embodiment of a component of radiopaque material of the present invention in the form of a disc 100, such as of titanium. Cutouts 102 are formed through the disc body, shown in FIG. 8 as the alphabetical letters “CT”. Disc 100 is affixed to the bottom surface 104 of housing base 106 in FIGS. 9 and 10, preferably within a complementary shallow recess 108 thereinto. A skirt 110 of silicone material is molded over the housing base, and is transparent so that the letters “CT” are visible from below but in a mirror-image orientation on the bottom outer surface of the housing base (FIG. 9) so that the indicia would appear as “CT” when the X-ray is viewed (FIG. 11), easily discerned by the radiologist or technologist. Centering of the indicia within the region directly beneath the reservoir and septum minimizes any obscuring by the structure of the venous access port assembly, and the indicia may also be easily discernable should the port assembly be at an angle from the horizontal plane of the X-ray.


In FIG. 12, an alternate embodiment of the present invention is shown, in which the disc 100 of FIG. 8 is embedded within the thickness of the bottom wall 130 of the housing base 132, and the X-ray would appear very similar to that shown in FIG. 11 but the indicia would not be visible from below the housing base or the port assembly.


A second embodiment of X-ray discernable indicia is shown in FIG. 13, and is utilized in the port assemblies of FIGS. 14 to 18. In FIG. 13, the indicia comprise a set of discrete indicia elements of radiopaque material, such as being stamped from a sheet of titanium. Again, as is preferred, the indicia comprise the alphabetical letters “C” and “T” and are utilized together as a set. In FIGS. 14 and 15, the discrete elements are embedded into the thickness of the bottom wall 204 of housing base 206, so that they would not be visible from below (see FIG. 14) even though the silicone overmolded skirt 208 is transparent. However, the discrete letters 202 would clearly be visible on an X-ray very similarly to the port assembly shown in FIG. 11. Another manner of using discrete letters 202 is depicted in FIGS. 16 to 18, in which the letters 202 are insert molded along the bottom surface 230 of housing base 232 and recessed thereinto, preferably. With this variant, the radiopaque material may be titanium or may be, for example, silicone material having barium sulfate filler. In this case the mirror-image of “CT” would be visible from below as depicted in FIG. 18 after the silicone overmolding of skirt 234 about the exterior of housing base 232.


It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.

Claims
  • 1. An implantable venous access port assembly, comprising: a needle-penetrable septum; anda housing securing the needle-penetrable septum, the housing comprising a housing base having a bottom wall and X-ray discernable indicia embedded in the bottom wall, the X-ray discernable indicia comprising one or more characters that visually indicate, under X-ray examination, a pressure property of the port assembly.
  • 2. The assembly of claim 1, wherein the X-ray discernable indicia are a set of discrete elements.
  • 3. The assembly of claim 2, wherein the discrete elements are of titanium.
  • 4. The assembly of claim 2, wherein the discrete elements are of silicone with barium sulfate filler.
  • 5. The assembly of claim 2, wherein the discrete elements are alphabetical letters.
  • 6. The assembly of claim 2, wherein the bottom wall comprises an outwardly facing bottom surface comprising one or more shallow recesses, and wherein the discrete elements are affixed in the one or more shallow recesses of the bottom surface so that the discrete elements are visible to an unaided eye prior to implantation of the assembly.
  • 7. The assembly of claim 2, wherein the discrete elements embedded in the bottom wall are embedded within a thickness of the bottom wall so that the discrete elements are not visible to an unaided eye prior to implantation of the assembly.
  • 8. The assembly of claim 6, wherein the discrete elements are arranged in a first orientation visible under visual inspection of the port assembly, which first orientation is a mirror image of a second orientation of an image of the discrete elements perceived during X-ray examination.
  • 9. The assembly of claim 6, wherein the housing comprises a skirt formed from radiotransparent material and molded around at least a portion of the housing base.
  • 10. The assembly of claim 1, wherein the X-ray discernable indicia comprise a disc of radiopaque material, the disc comprising cutouts that indicate the pressure property of the port assembly.
  • 11. The assembly of claim 10, wherein the cutouts are alphabetical letters.
  • 12. The assembly of claim 10, wherein the disc is titanium.
  • 13. The assembly of claim 10, wherein the bottom wall comprises an outwardly facing bottom surface comprising at least one shallow recess, and wherein the disc is affixed in the at least one shallow recess of the bottom surface so that the disc is visible to an unaided eye prior to implantation of the assembly.
  • 14. The assembly of claim 10, wherein the disc embedded in the bottom wall is embedded within a thickness of the bottom wall so that the disc is not visible to an unaided eye prior to implantation of the assembly.
  • 15. The assembly of claim 13, wherein the cutouts in the disc are arranged in a first orientation visible under visual inspection of the port assembly, which first orientation is a mirror image of a second orientation of an image of the cutouts perceived during X-ray examination.
  • 16. The assembly of claim 13, wherein the housing comprises a skirt formed from radiotransparent material and molded around at least a portion of the housing base.
  • 17. The assembly of claim 1, wherein the X-ray discernable indicia visually indicate, under X-ray examination, that the port assembly is rated to be used for power injection.
  • 18. The assembly of claim 17, wherein the X-ray discernable indicia further visually indicate, under X-ray examination, that the port assembly is adapted to withstand high pressures used for injection of contrast fluid.
  • 19. An implantable venous access port assembly, comprising: a housing comprising a housing base comprising a bottom wall and radiopaque indicia embedded in the bottom wall of the housing base, the radiopaque indicia comprising one or more characters indicating a pressure property of the port assembly under X-ray examination;a needle-penetrable septum; anda cap securing the needle-penetrable septum to the housing.
  • 20. The port assembly of claim 19, wherein: the bottom wall of the housing base comprises a bottom surface comprising one or more shallow recesses, andthe radiopaque indicia are affixed in the one or more shallow recesses of the bottom surface of the bottom wall, whereby the radiopaque indicia are visible by an unaided eye prior to implantation of the port assembly.
  • 21. The port assembly of claim 20, wherein the radiopaque indicia comprise a metal disc affixed in the one or more shallow recesses of the bottom surface of the bottom wall, the metal disc comprising one or more cutouts indicating the pressure property of the port assembly.
  • 22. The port assembly of claim 20, wherein the radiopaque indicia comprise one or more discrete metal elements separately affixed in the one or more shallow recesses of the bottom surface of the bottom wall.
  • 23. The port assembly of claim 19, wherein the radiopaque indicia are embedded into a thickness of the bottom wall of the housing base, whereby the radiopaque indicia are not visible by an unaided eye prior to implantation of the port assembly.
  • 24. The port assembly of claim 23, wherein the radiopaque indicia comprise a metal disc embedded into the thickness of the bottom wall of the housing base, the metal disc comprising one or more cutouts indicating the pressure property of the port assembly.
  • 25. The port assembly of claim 23, wherein the radiopaque indicia comprise one or more discrete metal elements separately embedded into the thickness of the bottom wall of the housing base.
  • 26. The port assembly of claim 19, wherein the radiopaque indicia indicate that the port assembly is rated to be used for power injection.
  • 27. The port assembly of claim 26, wherein the radiopaque indicia indicate that the port assembly is adapted to withstand high pressures used for injection of contrast fluid.
  • 28. An implantable venous access port assembly, comprising: a housing comprising a housing base and a skirt overmolded around at least a portion of the housing base, the housing base comprising a bottom wall and radiopaque indicia embedded in the bottom wall of the housing base, the radiopaque indicia comprising one or more characters indicating a pressure property of the port assembly under X-ray examination;a needle-penetrable septum; anda cap securing the needle-penetrable septum to the housing.
  • 29. The port assembly of claim 28, wherein: the bottom wall of the housing base comprises a bottom surface comprising one or more shallow recesses, andthe radiopaque indicia are affixed in the one or more shallow recesses of the bottom surface of the bottom wall.
  • 30. The port assembly of claim 29, wherein the radiopaque indicia comprise a metal disc affixed in the one or more shallow recesses of the bottom surface of the bottom wall, the metal disc comprising one or more cutouts indicating the pressure property of the port assembly.
  • 31. The port assembly of claim 30, wherein the overmolded skirt comprises a transparent material, whereby the metal disc comprising one or more cutouts is visible by an unaided eye prior to implantation of the port assembly.
  • 32. The port assembly of claim 29, wherein the radiopaque indicia comprise one or more discrete metal elements separately affixed in the one or more shallow recesses of the bottom surface of the bottom wall.
  • 33. The port assembly of claim 32, wherein the overmolded skirt comprises a transparent material, whereby the discrete metal elements are visible by an unaided eye prior to implantation of the port assembly.
  • 34. The port assembly of claim 28, wherein the radiopaque indicia are embedded into a thickness of the bottom wall of the housing base, whereby the radiopaque indicia are not visible by an unaided eye prior to implantation of the port assembly.
  • 35. The port assembly of claim 34, wherein the radiopaque indicia comprise a metal disc embedded into the thickness of the bottom wall of the housing base, the metal disc comprising one or more cutouts indicating the pressure property of the port assembly.
  • 36. The port assembly of claim 34, wherein the radiopaque indicia comprise one or more discrete metal elements separately embedded into the thickness of the bottom wall of the housing base.
  • 37. The port assembly of claim 28, wherein the radiopaque indicia indicate that the port assembly is rated to be used for power injection.
  • 38. The port assembly of claim 37, wherein the radiopaque indicia indicate that the port assembly is adapted to withstand high pressures used for injection of contrast fluid.
  • 39. The assembly of claim 1, wherein the one or more characters comprise one or more alphabetical letters.
  • 40. The assembly of claim 39, wherein the one or more alphabetical letters comprise the letters “CT.”
  • 41. The port assembly of claim 19, wherein the one or more characters comprise one or more alphabetical letters.
  • 42. The port assembly of claim 41, wherein the one or more alphabetical letters comprise the letters “CT.”
  • 43. The port assembly of claim 28, wherein the one or more characters comprise one or more alphabetical letters.
  • 44. The port assembly of claim 43, wherein the one or more alphabetical letters comprise the letters “CT.”
CROSS-REFERENCE TO RELATED APPLICATION

This claims the benefit of U.S. Provisional Patent Application Ser. No. 60/961,133 filed Jul. 19, 2007.

US Referenced Citations (321)
Number Name Date Kind
1713267 Crowley May 1929 A
2891689 Gould Jun 1959 A
D198453 Weichselbaum Jun 1964 S
3293663 Cronin Dec 1966 A
3341417 Sinaiko Sep 1967 A
3518428 Ring Jun 1970 A
3829904 Ling et al. Aug 1974 A
3831583 Edmunds, Jr. et al. Aug 1974 A
3915162 Miller Oct 1975 A
3919724 Sanders et al. Nov 1975 A
3951147 Tucker et al. Apr 1976 A
4027391 Samis et al. Jun 1977 A
4121108 Manor Oct 1978 A
4190040 Schulte Feb 1980 A
4194122 Mitchell et al. Mar 1980 A
4202349 Jones May 1980 A
4274006 Caine Jun 1981 A
4349498 Ellis et al. Sep 1982 A
4361153 Slocum et al. Nov 1982 A
4406567 Samis et al. Sep 1983 A
4445896 Gianturco May 1984 A
4450592 Niederer et al. May 1984 A
4456011 Warnecke et al. Jun 1984 A
4469483 Becker et al. Sep 1984 A
4494545 Slocum et al. Jan 1985 A
4543088 Bootman et al. Sep 1985 A
4549879 Groshong et al. Oct 1985 A
4559046 Groshong et al. Dec 1985 A
4576595 Aas et al. Mar 1986 A
4627844 Schmitt Dec 1986 A
4634427 Hannula et al. Jan 1987 A
4636213 Pakiam Jan 1987 A
4653508 Cosman Mar 1987 A
4655765 Swift Apr 1987 A
4662652 Hargis May 1987 A
4668221 Luther May 1987 A
4671796 Groshong et al. Jun 1987 A
4673394 Fenton, Jr. et al. Jun 1987 A
4684365 Reinicke Aug 1987 A
4685447 Iversen et al. Aug 1987 A
4685905 Jeanneret nee Aab Aug 1987 A
4692146 Hilger Sep 1987 A
4695273 Brown Sep 1987 A
4697595 Breyer et al. Oct 1987 A
4701166 Groshong et al. Oct 1987 A
4704103 Stober et al. Nov 1987 A
4718894 Lazorthes Jan 1988 A
4743231 Kay et al. May 1988 A
4753640 Nichols et al. Jun 1988 A
4755173 Konopka et al. Jul 1988 A
4760837 Petit Aug 1988 A
4762517 McIntyre et al. Aug 1988 A
4772270 Wiita et al. Sep 1988 A
4772276 Wiita et al. Sep 1988 A
4773552 Boege et al. Sep 1988 A
4778452 Moden et al. Oct 1988 A
4781680 Redmond et al. Nov 1988 A
4781685 Lehmann et al. Nov 1988 A
4802885 Weeks et al. Feb 1989 A
4820273 Reinicke Apr 1989 A
4840615 Hancock et al. Jun 1989 A
4848346 Crawford Jul 1989 A
4857053 Dalton Aug 1989 A
4861341 Woodburn Aug 1989 A
4863470 Carter Sep 1989 A
4886501 Johnston et al. Dec 1989 A
4915690 Cone et al. Apr 1990 A
4928298 Tanaka et al. May 1990 A
4929236 Sampson May 1990 A
4966583 Debbas Oct 1990 A
4973319 Melsky Nov 1990 A
5009644 McDonald Apr 1991 A
5013298 Moden et al. May 1991 A
5041098 Loiterman et al. Aug 1991 A
5044955 Jagmin Sep 1991 A
5045060 Melsky et al. Sep 1991 A
5084015 Moriuchi Jan 1992 A
5085216 Henley, Jr. et al. Feb 1992 A
5090066 Schoepe et al. Feb 1992 A
5092849 Sampson Mar 1992 A
5108317 Beinhaur et al. Apr 1992 A
5108377 Cone et al. Apr 1992 A
5112301 Fenton, Jr. et al. May 1992 A
5112303 Pudenz et al. May 1992 A
5137529 Watson et al. Aug 1992 A
5147483 Melsky et al. Sep 1992 A
5152753 Laguette et al. Oct 1992 A
5156600 Young Oct 1992 A
5167629 Vertenstein et al. Dec 1992 A
5167638 Felix et al. Dec 1992 A
5176653 Metals et al. Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5178612 Fenton, Jr. Jan 1993 A
5185003 Brethauer Feb 1993 A
5189690 Samuel Feb 1993 A
5193106 DeSena Mar 1993 A
5195122 Fabian Mar 1993 A
5201715 Masters Apr 1993 A
5203777 Lee Apr 1993 A
5213574 Tucker May 1993 A
5215537 Lynn et al. Jun 1993 A
5222499 Allen et al. Jun 1993 A
D337637 Tucker Jul 1993 S
5224938 Fenton, Jr. Jul 1993 A
5281205 McPherson Jan 1994 A
5295658 Atkinson et al. Mar 1994 A
5299253 Wessels Mar 1994 A
5309863 Leeb, Jr. May 1994 A
5318545 Tucker Jun 1994 A
5320100 Herweck et al. Jun 1994 A
5328480 Melker et al. Jul 1994 A
5332398 Miller et al. Jul 1994 A
5338398 Szwejkowski et al. Aug 1994 A
5352204 Ensminger Oct 1994 A
5360407 Leonard Nov 1994 A
5383233 Russell Jan 1995 A
5383858 Reilly et al. Jan 1995 A
D355240 Gladfelter et al. Feb 1995 S
5387192 Glantz et al. Feb 1995 A
5394457 Leibinger et al. Feb 1995 A
5397329 Allen Mar 1995 A
5405402 Dye et al. Apr 1995 A
5417565 Long May 1995 A
5417656 Ensminger et al. May 1995 A
5423334 Jordan Jun 1995 A
5456698 Byland et al. Oct 1995 A
5476460 Montalvo Dec 1995 A
5476880 Cooke et al. Dec 1995 A
5484402 Saravia et al. Jan 1996 A
5507813 Dowd et al. Apr 1996 A
5509805 Jagmin Apr 1996 A
5513637 Twiss et al. May 1996 A
5556381 Ensminger et al. Sep 1996 A
5558641 Glantz et al. Sep 1996 A
5607407 Tolkoff et al. Mar 1997 A
5613945 Cai et al. Mar 1997 A
5620419 Lui et al. Apr 1997 A
5637102 Tolkoff et al. Jun 1997 A
5662612 Niehoff Sep 1997 A
5676146 Scarborough Oct 1997 A
5695490 Flaherty et al. Dec 1997 A
5702128 Maxim et al. Dec 1997 A
5704915 Melsky et al. Jan 1998 A
5709668 Wacks Jan 1998 A
5713858 Heruth et al. Feb 1998 A
5713859 Finch, Jr. et al. Feb 1998 A
5718382 Jaeger Feb 1998 A
5718682 Tucker Feb 1998 A
5725507 Petrick Mar 1998 A
5733400 Gore et al. Mar 1998 A
5743873 Cai et al. Apr 1998 A
5743891 Tolkoff et al. Apr 1998 A
5773552 Hutchings et al. Jun 1998 A
5792104 Speckman et al. Aug 1998 A
5792116 Berg et al. Aug 1998 A
5824071 Nelson et al. Oct 1998 A
5833654 Powers et al. Nov 1998 A
5843069 Butler et al. Dec 1998 A
5853394 Tolkoff et al. Dec 1998 A
5868702 Stevens et al. Feb 1999 A
5895424 Steele, Sr. et al. Apr 1999 A
5913998 Butler et al. Jun 1999 A
5928197 Niehoff Jul 1999 A
5931829 Burbank et al. Aug 1999 A
5944688 Lois Aug 1999 A
5944712 Frassica et al. Aug 1999 A
5947953 Ash et al. Sep 1999 A
5951512 Dalton Sep 1999 A
5951522 Rosato et al. Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5970162 Kawashima et al. Oct 1999 A
5989216 Johnson et al. Nov 1999 A
5989239 Finch et al. Nov 1999 A
5997524 Burbank et al. Dec 1999 A
6007516 Burbank et al. Dec 1999 A
6013058 Prosl et al. Jan 2000 A
6017331 Watts et al. Jan 2000 A
6022335 Ramadan Feb 2000 A
6033389 Cornish Mar 2000 A
6039712 Fogarty et al. Mar 2000 A
6077756 Lin et al. Jun 2000 A
6086555 Eliasen Jul 2000 A
6090066 Schnell Jul 2000 A
6113572 Gailey et al. Sep 2000 A
6120492 Finch et al. Sep 2000 A
6161033 Kuhn Dec 2000 A
6171198 Lizama Troncoso et al. Jan 2001 B1
6171298 Matsuura et al. Jan 2001 B1
6190352 Haarala et al. Feb 2001 B1
6193684 Burbank et al. Feb 2001 B1
6198807 DeSena Mar 2001 B1
6213973 Eliasen et al. Apr 2001 B1
6251059 Apple et al. Jun 2001 B1
D445175 Bertheas Jul 2001 S
6269148 Jessop et al. Jul 2001 B1
6287293 Jones et al. Sep 2001 B1
6290677 Arai et al. Sep 2001 B1
6305413 Fischer et al. Oct 2001 B1
D450115 Bertheas Nov 2001 S
6355021 Nielsen et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6398764 Finch, Jr. et al. Jun 2002 B1
6419680 Cosman et al. Jul 2002 B1
6478783 Moorehead Nov 2002 B1
6494867 Elver et al. Dec 2002 B1
6500155 Sasso Dec 2002 B2
6503228 Li et al. Jan 2003 B1
6527754 Tallarida et al. Mar 2003 B1
6537255 Raines Mar 2003 B1
6582418 Verbeek et al. Jun 2003 B1
6613002 Clark et al. Sep 2003 B1
6613662 Wark et al. Sep 2003 B2
6632217 Harper et al. Oct 2003 B2
6652486 Bialecki et al. Nov 2003 B2
6652503 Bradley Nov 2003 B1
6676633 Smith et al. Jan 2004 B2
6697664 Kienzle, III et al. Feb 2004 B2
6719721 Okazaki et al. Apr 2004 B1
6738531 Funahashi May 2004 B1
6826257 Sayre et al. Nov 2004 B2
6852106 Watson et al. Feb 2005 B2
6878136 Fleury et al. Apr 2005 B2
6878137 Benchetrit Apr 2005 B2
6997914 Smith et al. Feb 2006 B2
7016456 Basu et al. Mar 2006 B2
7072704 Bucholz Jul 2006 B2
7127040 Sayre et al. Oct 2006 B2
7191011 Cantlon Mar 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7223257 Shubayev et al. May 2007 B2
7229417 Foerster et al. Jun 2007 B2
7235067 Morris et al. Jun 2007 B2
D546440 Burnside Jul 2007 S
7252469 Zaluzec et al. Aug 2007 B2
7252649 Sherry Aug 2007 B2
7261705 Edoga et al. Aug 2007 B2
D554253 Kornerup Oct 2007 S
7275682 Excoffier et al. Oct 2007 B2
D556153 Burnside Nov 2007 S
7318816 Bobroff et al. Jan 2008 B2
7318818 Yashiro et al. Jan 2008 B2
7322953 Redinger Jan 2008 B2
D562443 Zinn et al. Feb 2008 S
7331130 Schweikert Feb 2008 B2
7331948 Skarda Feb 2008 B2
7333013 Berger Feb 2008 B2
7347838 Kulli Mar 2008 B2
D574950 Zawacki et al. Aug 2008 S
7413564 Morris et al. Aug 2008 B2
7445614 Bunodiere et al. Nov 2008 B2
7465847 Fabian Dec 2008 B2
20010053889 Marggi et al. Dec 2001 A1
20010056266 Tallarida et al. Dec 2001 A1
20020138068 Watson et al. Sep 2002 A1
20030130627 Smith et al. Jul 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20030181878 Tallarida et al. Sep 2003 A1
20040020462 Sauler et al. Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040056266 Suh et al. Mar 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040167543 Mazzocchi et al. Aug 2004 A1
20040176743 Morris et al. Sep 2004 A1
20040199129 DiMatteo Oct 2004 A1
20040199220 Cantlon Oct 2004 A1
20040204692 Eliasen Oct 2004 A1
20050049553 Triplett et al. Mar 2005 A1
20050075614 Bunodiere et al. Apr 2005 A1
20050113806 DeCarvalho et al. May 2005 A1
20050152841 Sayre et al. Jul 2005 A1
20050182857 Kong Aug 2005 A1
20050209573 Brugger et al. Sep 2005 A1
20050215874 Wang et al. Sep 2005 A1
20050241203 Lizotte et al. Nov 2005 A1
20050256500 Fujii Nov 2005 A1
20050283119 Uth et al. Dec 2005 A1
20060009788 Freeman et al. Jan 2006 A1
20060116648 Hamatake Jun 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060178647 Stats Aug 2006 A1
20060217659 Patton Sep 2006 A1
20060224129 Beasley et al. Oct 2006 A1
20060247584 Sheetz et al. Nov 2006 A1
20060253076 Butts et al. Nov 2006 A1
20060264898 Beasley et al. Nov 2006 A1
20070049876 Patton Mar 2007 A1
20070055290 Lober Mar 2007 A1
20070073250 Schneiter Mar 2007 A1
20070078391 Wortley et al. Apr 2007 A1
20070078416 Eliasen Apr 2007 A1
20070078432 Halseth et al. Apr 2007 A1
20070083156 Muto et al. Apr 2007 A1
20070149920 Michels et al. Jun 2007 A1
20070149921 Michels et al. Jun 2007 A1
20070161958 Glenn Jul 2007 A1
20070185462 Byrum Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070208313 Conlon et al. Sep 2007 A1
20070219510 Zinn et al. Sep 2007 A1
20070233017 Zinn et al. Oct 2007 A1
20070233018 Bizup et al. Oct 2007 A1
20070270770 Bizup Nov 2007 A1
20070276344 Bizup et al. Nov 2007 A1
20070299408 Alferness et al. Dec 2007 A1
20080004642 Birk et al. Jan 2008 A1
20080008654 Clarke et al. Jan 2008 A1
20080015701 Garcia et al. Jan 2008 A1
20080039820 Sommers et al. Feb 2008 A1
20080048855 Berger Feb 2008 A1
20080108949 Beasley et al. May 2008 A1
20080140025 Sheetz et al. Jun 2008 A1
20080208236 Hobbs et al. Aug 2008 A1
20080319399 Schweikert et al. Dec 2008 A1
20090024024 Zinn Jan 2009 A1
20090024098 Bizup et al. Jan 2009 A1
20090118683 Hanson et al. May 2009 A1
20090156928 Evans et al. Jun 2009 A1
20090204072 Amin et al. Aug 2009 A1
Foreign Referenced Citations (21)
Number Date Country
0619101 Oct 1994 EP
WO 8600213 Jan 1986 WO
WO 9305730 Apr 1993 WO
WO 9701370 Jan 1997 WO
WO 9942166 Aug 1999 WO
WO 0033901 Jun 2000 WO
WO 0247549 Jun 2002 WO
WO 2004004800 Jan 2004 WO
WO 2006096686 Sep 2006 WO
WO2006116438 Nov 2006 WO
WO 2007079024 Jul 2007 WO
WO 2007136538 Nov 2007 WO
WO 2008008126 Jan 2008 WO
WO 2008019236 Feb 2008 WO
WO 2008048361 Apr 2008 WO
WO 2008063226 May 2008 WO
WO 2008157763 Dec 2008 WO
WO 2009012385 Jan 2009 WO
WO 2009012395 Jan 2009 WO
WO 2009035582 Mar 2009 WO
WO 2009046439 Apr 2009 WO
Related Publications (1)
Number Date Country
20090024098 A1 Jan 2009 US
Provisional Applications (1)
Number Date Country
60961133 Jul 2007 US